尚志芳, 朱玉群, 杨昭徐. 四项肿瘤标志物联合检测对胰腺癌的诊断价值[J]. 疾病监测, 1996, 11(11): 408-411. DOI: 10.3784/j.issn.1003-9961.1996.11.408
引用本文: 尚志芳, 朱玉群, 杨昭徐. 四项肿瘤标志物联合检测对胰腺癌的诊断价值[J]. 疾病监测, 1996, 11(11): 408-411. DOI: 10.3784/j.issn.1003-9961.1996.11.408
Shang Zhifan et al, . Clinical Evaluation of Combined Use of CA19-9,CA50antigen,SF and CEA in the Serum of Patients with Pancreatic Carcinoma[J]. Disease Surveillance, 1996, 11(11): 408-411. DOI: 10.3784/j.issn.1003-9961.1996.11.408
Citation: Shang Zhifan et al, . Clinical Evaluation of Combined Use of CA19-9,CA50antigen,SF and CEA in the Serum of Patients with Pancreatic Carcinoma[J]. Disease Surveillance, 1996, 11(11): 408-411. DOI: 10.3784/j.issn.1003-9961.1996.11.408

四项肿瘤标志物联合检测对胰腺癌的诊断价值

Clinical Evaluation of Combined Use of CA19-9,CA50antigen,SF and CEA in the Serum of Patients with Pancreatic Carcinoma

  • 摘要: 本文对21例胰腺癌患者及56例良性消化系疾患者测定癌抗原19-9(CA19-9)和癌抗原50(CA50),铁蛋白(SF)及癌胚抗原(CEA),发现胰腺癌组四项指标的血浓度及检出率均高于对照组,具有统计学差异(iP/i0.01),其中以CA19-9敏感性最高,为76.19%,其次为CA50,二者均具较高的特异性及临床符合率。选择CA19-9与其他肿瘤标志物联合检测,显示CA19-9+CA50或SF,阳性率为85.71%,但与各单项标志物比较无明显差异,全部四项标志物同时检测,临床敏感性达100%,与各单指标比较差异显著,但特异性有所降低。结果表明,CA19-9和CA50为胰腺癌诊断较为理想的标志物,若两者联合或与SF及CEA组合检测,对提高胰腺癌诊断的敏感性,用于可疑患者的筛查具有较好的应用价值。

     

    Abstract: In this study,the serun values of carbohydrate antigen(CA19-9 CA50),serum ferritin(SF) and carcinoembryonic antigen (CEA)were measured in 21 patients with pancreatic carcinoma(PC) and 56 patients with benign diseases of digestive system.Serum concentrations of various markers and positive rate in Patients were significantly higher than those in the control group,the value between patients and controls was statistically different(P0.01).The sensitivity of CA19-9 was the highest 76.19%,the second was CA50 and both showed high specificity and diagnostic accuracy.The positive rate of combination of CA19-9 and CA50 was 85.71%,but did not exceed that of each marker test alone.The cambined use of these four cuncer markers elevated sensitivity to 100%,which remarkably discriminated with each test used alone,whereas specificity decreased.So it was concluded that CA19-9 and CA50 could serve as valuble indicaters in the diagnosis of PC.The combined assay of CA19-9+CA50 or SF+CEA could enhance the sensitivity in diagnosis of malignant pacreatic diseases also was of sufficient value for screening patients with a suspicion to have pancreatic cancer.

     

/

返回文章
返回